Leprosy cost-effectiveness of therapy: Difference between revisions
Joao Silva (talk | contribs) |
Joao Silva (talk | contribs) |
||
| Line 7: | Line 7: | ||
==Cost-effectiveness of Therapy== | ==Cost-effectiveness of Therapy== | ||
The results of the [[WHO]] measures | The results of the [[WHO]] measures show that with adequate investment in [[prevention]] and early [[Therapy|treatment]] of the [[disease]], it is possible to minimize its [[incidence]] around the world. Therefore, [[therapy]] and [[research]] of new and innovative techniques may be considered cost-effective in the case of leprosy.<ref name=WHO>{{cite web | title = Leprosy: global situation | url = http://www.who.int/lep/situation/en/ }}</ref> | ||
==References== | ==References== | ||
Revision as of 21:50, 8 July 2014
|
Leprosy Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Leprosy cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Leprosy cost-effectiveness of therapy |
|
Risk calculators and risk factors for Leprosy cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]
Overview
After the results of the campaign of the WHO to eradicate leprosy, the treatment of this disease may be considered cost-effective.
Cost-effectiveness of Therapy
The results of the WHO measures show that with adequate investment in prevention and early treatment of the disease, it is possible to minimize its incidence around the world. Therefore, therapy and research of new and innovative techniques may be considered cost-effective in the case of leprosy.[1]